Revvity, Inc. (RVTY)
RVTYNYSEBiotechnology: Laboratory Analytical Instruments
$160.72
+5.61 (+3.62%) today
Closed, Nov 9, 4:00 PM ET
- Market cap
- $17.94bn
- P/E
- 29.0
- EPS, last 4 quarters
- $5.55
- Dividend yield
- –
- Day range
- –
- 52-week range
- $81.22 to $171.74
- Average volume
- –
- Previous close
- $155.11
Analysts
14 coveringHold6 buy, 8 hold, 0 sell
Targets a year out average $166.85, +3.8% from here
Earnings
next estimate $1.61Next report
Dec 2025
+6.9%
Mar 2026
+3.9%
Jun 2026
+14.6%
Sep 2026
+7.0%
estimate reported, and the surprise
Financials
| Quarter | Sep 2025 | Dec 2025 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|
| Revenue | $698.95m | $772.06m | $711.12m | $729.69m |
| Gross profit | $374.60m | $421.66m | $387.65m | $416.87m |
| Operating income | $81.90m | $111.75m | $75.89m | $89.32m |
| Net income | $46.65m | $98.36m | $40.72m | $51.82m |
Last four quarters: revenue $2.91bn, margin 8.2%, free cash flow $558.11m
News
8 latest- Revvity Consensus Price Target Raised 18.01% to $174.65Fintel · 3 hours ago
- All You Need to Know About Revvity (RVTY) Rating Upgrade to BuyZacks · 4 days ago
- Stocks Finished Mostly Higher on Chipmaker StrengthBarchart · 6 days ago
- Revvity Q3 Earnings Call HighlightsMarketBeat · 6 days ago
- Stocks Supported by Strength in ChipmakersBarchart · 6 days ago
- Stocks Rebound as Crude Oil Prices Fall and Chipmakers RecoverBarchart · 6 days ago
- Revvity (RVTY) Q3 2026 Earnings Call TranscriptThe Motley Fool · 6 days ago
- Revvity, Inc. Reports Third Quarter 2026 Financial ResultsFintel · 7 days ago
The company
Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what's possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With 2025 revenue of $2.9 billion and approximately 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 160 countries.
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Exchange
- NYSE
- Region
- North America
- Website
- revvity.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.